Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
OCULAR THERAPEUTIX, INC (OCUL)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
BUY
26 Feb 2024
SUMMER ROAD LLC
10% Owner
OCULAR THERAPEUTIX, INC
(OCUL)
8,591,401
+12%
930,851
$7.52
$6,999,999.50
BUY
3 Feb 2024
Mattessich Antony C.
President and CEO, Director, Officer
OCULAR THERAPEUTIX, INC
(OCUL)
588,701
+3%
19,642
$4.86
$95,460.13
BUY
3 Feb 2024
Notman Donald
Chief Financial Officer, Officer
OCULAR THERAPEUTIX, INC
(OCUL)
195,356
+3%
6,212
$4.86
$30,190.32
BUY
3 Feb 2024
Ozden Rabia Gurses
Chief Medical Officer, Officer
OCULAR THERAPEUTIX, INC
(OCUL)
153,054
+4%
6,346
$4.86
$30,841.56
BUY
3 Feb 2024
Strassburger Philip C.
General Counsel, Officer
OCULAR THERAPEUTIX, INC
(OCUL)
161,493
+3%
6,029
$4.86
$29,300.94
BUY
3 Feb 2024
White Christopher G
Chief Business Officer, Officer
OCULAR THERAPEUTIX, INC
(OCUL)
123,689
+5%
5,910
$4.86
$28,722.60
SELL
31 Jan 2024
Strassburger Philip C.
General Counsel, Officer
OCULAR THERAPEUTIX, INC
(OCUL)
109,218
-5%
6,831
$4.95
$33,813.45
SELL
31 Jan 2024
White Christopher G
Chief Business Officer, Officer
OCULAR THERAPEUTIX, INC
(OCUL)
89,619
-5%
5,147
$4.95
$25,477.65
SELL
31 Jan 2024
Mattessich Antony C.
President and CEO, Director, Officer
OCULAR THERAPEUTIX, INC
(OCUL)
427,943
-4%
18,338
$4.95
$90,773.09
SELL
31 Jan 2024
Notman Donald
Chief Financial Officer, Officer
OCULAR THERAPEUTIX, INC
(OCUL)
139,932
-4%
6,433
$4.95
$31,843.35
SELL
31 Jan 2024
Ozden Rabia Gurses
Chief Medical Officer, Officer
OCULAR THERAPEUTIX, INC
(OCUL)
92,767
-7%
7,764
$4.95
$38,431.80
BUY
14 Dec 2023
SUMMER ROAD LLC
10% Owner
OCULAR THERAPEUTIX, INC
(OCUL)
7,660,550
+25%
1,538,461
$3.25
$4,999,998.00
BUY
30 Aug 2023
Mattessich Antony C.
President and CEO, Director, Officer
OCULAR THERAPEUTIX, INC
(OCUL)
6,500
+100%
6,500
$3.81
$24,765.00
SELL
7 Jul 2023
Ozden Rabia Gurses
Chief Medical Officer, Officer
OCULAR THERAPEUTIX, INC
(OCUL)
100,531
-0%
832
$4.93
$4,101.76
SELL
6 Feb 2023
Mattessich Antony C.
President and CEO, Director, Officer
OCULAR THERAPEUTIX, INC
(OCUL)
446,281
-4%
19,669
$4.24
$83,396.56
SELL
6 Feb 2023
Strassburger Philip C.
General Counsel, Officer
OCULAR THERAPEUTIX, INC
(OCUL)
109,071
-5%
6,181
$4.24
$26,207.44
SELL
6 Feb 2023
Ozden Rabia Gurses
Chief Medical Officer, Officer
OCULAR THERAPEUTIX, INC
(OCUL)
101,363
-5%
6,416
$4.24
$27,203.84
SELL
6 Feb 2023
Notman Donald
Chief Financial Officer, Officer
OCULAR THERAPEUTIX, INC
(OCUL)
139,387
-4%
6,476
$4.24
$27,458.24
SELL
6 Feb 2023
White Christopher G
Chief Business Officer, Officer
OCULAR THERAPEUTIX, INC
(OCUL)
94,766
-5%
5,829
$4.24
$24,714.96
BUY
7 Nov 2022
SUMMER ROAD LLC
10% Owner
OCULAR THERAPEUTIX, INC
(OCUL)
6,122,089
+0%
7,328
$3.50
$25,648.00
BUY
10 Oct 2022
SUMMER ROAD LLC
10% Owner
OCULAR THERAPEUTIX, INC
(OCUL)
6,114,761
+0%
20,000
$3.95
$78,975.00
BUY
27 Sep 2022
SUMMER ROAD LLC
10% Owner
OCULAR THERAPEUTIX, INC
(OCUL)
6,094,761
+2%
150,000
$4.59
$689,229.75
BUY
12 May 2022
Heier Jeffrey S.
Director
OCULAR THERAPEUTIX, INC
(OCUL)
39,000
+62%
15,000
$3.05
$45,750.00
BUY
18 Feb 2022
SUMMER ROAD LLC
10% Owner
OCULAR THERAPEUTIX, INC
(OCUL)
5,944,761
+0%
50,000
$4.96
$247,926.00
BUY
27 Jan 2022
SUMMER ROAD LLC
10% Owner
OCULAR THERAPEUTIX, INC
(OCUL)
5,894,761
+0%
5,500
$5.20
$28,600.00
BUY
20 Jan 2022
SUMMER ROAD LLC
10% Owner
OCULAR THERAPEUTIX, INC
(OCUL)
5,889,261
+1%
74,500
$5.45
$405,808.25
BUY
13 Jan 2022
SUMMER ROAD LLC
10% Owner
OCULAR THERAPEUTIX, INC
(OCUL)
5,814,761
+0%
50,000
$6.06
$302,920.66
BUY
14 Dec 2021
SUMMER ROAD LLC
10% Owner
OCULAR THERAPEUTIX, INC
(OCUL)
5,764,761
+0%
44,490
$6.35
$282,421.38
BUY
10 Dec 2021
SUMMER ROAD LLC
10% Owner
OCULAR THERAPEUTIX, INC
(OCUL)
5,720,271
+0%
40,510
$6.61
$267,796.38
BUY
6 Dec 2021
SUMMER ROAD LLC
10% Owner
OCULAR THERAPEUTIX, INC
(OCUL)
5,679,761
+1%
60,900
$6.18
$376,603.00
BUY
20 Aug 2021
Mattessich Antony C.
President and CEO, Director, Officer
OCULAR THERAPEUTIX, INC
(OCUL)
102,900
+5%
5,000
$9.89
$49,450.00
SELL
20 May 2021
LINDSTROM RICHARD L MD
Director
OCULAR THERAPEUTIX, INC
(OCUL)
90,000
-10%
10,000
$14.30
$143,000.00
BUY
16 Oct 2020
SUMMER ROAD LLC
10% Owner
OCULAR THERAPEUTIX, INC
(OCUL)
5,618,861
+0%
437
$10.48
$4,579.76
BUY
19 May 2020
SUMMER ROAD LLC
10% Owner
OCULAR THERAPEUTIX, INC
(OCUL)
5,618,424
+6%
363,636
$5.50
$1,999,998.00
BUY
20 Mar 2020
SUMMER ROAD LLC
10% Owner
OCULAR THERAPEUTIX, INC
(OCUL)
5,254,788
+2%
109,100
$4.71
$514,198.40
BUY
18 Mar 2020
SUMMER ROAD LLC
10% Owner
OCULAR THERAPEUTIX, INC
(OCUL)
5,145,688
+8%
385,838
$4.62
$1,783,423.80
BUY
13 Mar 2020
SUMMER ROAD LLC
10% Owner
OCULAR THERAPEUTIX, INC
(OCUL)
4,759,850
+25%
955,062
$4.55
$4,346,090.00
BUY
2 Jan 2020
Opaleye Management Inc.
10% Owner
OCULAR THERAPEUTIX, INC
(OCUL)
4,918,500
+0%
15,000
$3.90
$58,507.50
BUY
30 Dec 2019
Opaleye Management Inc.
10% Owner
OCULAR THERAPEUTIX, INC
(OCUL)
4,903,500
+0%
20,000
$3.97
$79,410.00
BUY
14 Jun 2019
Williams Leslie J.
Director
OCULAR THERAPEUTIX, INC
(OCUL)
4,500
+100%
4,500
$4.40
$19,800.00
BUY
14 Jun 2019
Notman Donald
Chief Financial Officer, Officer
OCULAR THERAPEUTIX, INC
(OCUL)
24,049
+11%
2,500
$4.33
$10,825.00
BUY
6 Jun 2019
Mattessich Antony C.
President & CEO, Director, Officer
OCULAR THERAPEUTIX, INC
(OCUL)
97,900
+69%
40,000
$2.81
$112,400.00
BUY
6 Jun 2019
Sawhney Amarpreet
Chairman of the Board, Director, Officer
OCULAR THERAPEUTIX, INC
(OCUL)
1,056,031
+13%
124,468
$2.92
$362,913.38
BUY
4 Jun 2019
Sawhney Amarpreet
Chairman of the Board, Director, Officer
OCULAR THERAPEUTIX, INC
(OCUL)
931,563
+5%
45,780
$2.91
$133,349.08
BUY
28 May 2019
Goldstein Michael H.
Chief Medical Officer, Officer
OCULAR THERAPEUTIX, INC
(OCUL)
25,686
+87%
12,000
$2.51
$30,120.00
BUY
15 Mar 2019
Goldstein Michael H.
Chief Medical Officer, Officer
OCULAR THERAPEUTIX, INC
(OCUL)
13,686
+271%
10,000
$4.15
$41,500.00
BUY
15 Mar 2019
Heier Jeffrey S.
Director
OCULAR THERAPEUTIX, INC
(OCUL)
24,000
+100%
24,000
$4.15
$99,600.00
BUY
13 Mar 2019
LINDSTROM RICHARD L MD
Director
OCULAR THERAPEUTIX, INC
(OCUL)
100,000
+129%
56,441
$4.33
$244,389.53
BUY
14 Dec 2018
Hanley Kevin F.
See Remarks, Officer
OCULAR THERAPEUTIX, INC
(OCUL)
20,000
+100%
10,000
$5.50
$55,000.00
BUY
10 Dec 2018
Hanley Kevin F.
SEE REMARKS, Officer
OCULAR THERAPEUTIX, INC
(OCUL)
10,000
+100%
10,000
$5.60
$56,000.00
BUY
6 Dec 2018
Bollag Daniel M
See Remarks, Officer
OCULAR THERAPEUTIX, INC
(OCUL)
42,100
+70%
17,400
$5.76
$100,224.01
BUY
20 Aug 2018
Mattessich Antony C.
President & CEO, Director, Officer
OCULAR THERAPEUTIX, INC
(OCUL)
57,900
+52%
20,000
$5.95
$119,000.00
BUY
14 Aug 2018
Notman Donald
Chief Financial Officer, Officer
OCULAR THERAPEUTIX, INC
(OCUL)
17,300
+260%
12,500
$6.29
$78,625.00
BUY
10 Aug 2018
Mattessich Antony C.
President and CEO, Director, Officer
OCULAR THERAPEUTIX, INC
(OCUL)
37,900
+80%
16,900
$6.23
$105,287.00
BUY
12 Dec 2017
Mattessich Antony C.
President and C.E.O., Director, Officer
OCULAR THERAPEUTIX, INC
(OCUL)
21,000
+100%
21,000
$4.29
$90,090.00
BUY
7 Dec 2017
Bollag Daniel M
See Remarks, Officer
OCULAR THERAPEUTIX, INC
(OCUL)
24,700
+100%
24,700
$3.93
$97,071.00
BUY
7 Dec 2017
Notman Donald
Chief Financial Officer, Officer
OCULAR THERAPEUTIX, INC
(OCUL)
4,800
+100%
4,800
$4.00
$19,200.00
BUY
16 Nov 2017
Sawhney Amarpreet
Exec. Chairman of the Board, Director, Officer, 10% Owner
OCULAR THERAPEUTIX, INC
(OCUL)
696,390
+2%
19,000
$5.18
$98,420.00
BUY
15 Dec 2016
Sawhney Amarpreet
President and CEO, Director, Officer, 10% Owner
OCULAR THERAPEUTIX, INC
(OCUL)
677,390
+7%
45,300
$7.85
$355,605.00
BUY
9 Jun 2016
Sawhney Amarpreet
President and CEO, Director, Officer, 10% Owner
OCULAR THERAPEUTIX, INC
(OCUL)
573,733
+1%
10,000
$6.70
$67,000.00
Home